Physician profile
Jonathan B Kao
NPI 1295779684
$977.96
in general payments reported to CMS, 2019-2025
11 companies · $32.62 in 2025
The $32.62 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $52.82 · 2021: $85.37 · 2022: $275 · 2023: $292 · 2024: $98.43 · 2025: $32.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $394.97 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Glaukos Corporation | $126.59 | 2019-2022 | |
| Dompe US, INC. | $102.57 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $73.65 | 2023 | Clarus |
| Heidelberg Engineering, INC. | $67.73 | 2023 | Spectralis |
| Johnson & Johnson Surgical Vision, INC. | $55.68 | 2019-2025 | Tecnis Simplicity |
| Carl Zeiss Meditec, INC. | $52.82 | 2020 | |
| Bausch & Lomb Americas INC. | $33.95 | 2023-2025 | Scoutpro Osmolarity System, Toric |
| Ivantis, INC | $32.35 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Kao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.